Drug Target Review2025-02-21T09:00:18
A new UCLA study reveals that DNA mismatch repair genes play a crucial role in Huntington’s disease by driving neuronal damage and motor impairments. Targeting these genes, especially Msh3 and Pms1, could offer promising therapeutic avenues for the disease.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-08-20T08:43:00Z
Author Dr Daniel Tillett
2023-03-03T14:06:14
Sponsored by Bio-Techne
2024-01-19T07:40:55
Sponsored by Euretos
2024-03-08T10:00:25
Sponsored by Molecular Devices
2023-07-11T16:13:06
Sponsored by Agilent
2023-02-16T14:53:10
Sponsored by Cell Signaling Technology
2026-08-20T08:43:00
Author Dr Daniel Tillett
Site powered by Webvision Cloud